Unraveling the Pathogenesis of Influenza-associated Aspergillosis: a Single-center, Prospective Cohort Pilot Study

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

This trial is aimed to study the immunological and pathological characteristics of influenza versus non-influenza severe community-acquired pneumonia patients in ICU.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• All patients older than 18 years, admitted to ICU with respiratory distress with microbiologically confirmed diagnosis of influenza (for inclusion in the influenza group)

• All patients older than 18 years, admitted to ICU for respiratory distress due to community- acquired pneumonia , with a microbiologically confirmed absence of influenza (for inclusion in the control group)

Locations
Other Locations
Belgium
Universitaire Ziekenhuizen Leuven
RECRUITING
Leuven
Contact Information
Primary
Joost Wauters, PhD
joost.wauters@uzleuven.be
16344275
Backup
Lore Vanderbeke, MD
lore.vanderbeke@uzleuven.be
16344275
Time Frame
Start Date: 2019-01-18
Estimated Completion Date: 2025-04
Participants
Target number of participants: 45
Treatments
Influenza positive CAPIV
All consecutive patients older than 18 years, admitted to the ICU with respiratory distress with microbiologically confirmed diagnosis of influenza
Influenza negative CAPIV
All consecutive patients older than 18 years, admitted to the ICU for respiratory distress due to community-acquired pneumonia (CAP) and with a microbiologically confirmed absence of influenza
Related Therapeutic Areas
Sponsors
Leads: Universitaire Ziekenhuizen KU Leuven

This content was sourced from clinicaltrials.gov